Skip to main content

Table 2. Patients’ characteristics

From: COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU

Characteristics Survivors (n=91) Non-survivors (n=89) P value
No. % No. %
Age 0.000*
 <60 46 25.56 19 10.56  
 ≥60 45 25.00 70 38.89  
Sex 0.335
 Male 54 30.00 59 32.78  
 Female 37 20.56 30 16.67  
Cancer history 0.003*
 Yes 0   8 4.44  
 No 91 50.56 81 45.00  
Diabetes history 0.156
 Yes 13 7.22 20 11.11  
 No 78 43.33 69 38.33  
VTE history 0.321
 Yes 1 0.56 0   
 No 90 50.00 89 49.44  
  1. VTE venous thromboembolism
  2. *Statistically significant